Kinarus Therapeutics Holding AG / Key word(s): Research Update/Study Kinarus Therapeutics Phase 2 KINFAST Covid-19 Clinical Trial Progress Update 21.02.2023 / 07:00 CET/CEST MEDIA RELEASE KINFAST is evaluating KIN001 for reduction in severity and duration of Covid-19 symptoms KINFAST is actively.
Kinarus Therapeutics Holding AG / Key word(s): Research Update/Study results Kinarus Therapeutics Reports Preclinical Data in Lung Fibrosis and Discloses Clinical Development Plan 17.01.2023
Kinarus Therapeutics Reports Preclinical Data in Lung Fibrosis and Discloses Clinical Development Plan streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Kinarus Therapeutics Holding AG / Key word(s): Research Update/Study resultsKinarus Therapeutics Reports Preclinical Data in Lung Fibrosis and Discloses Clinical Development Plan 17.01.2023 / 07:00 CET/CESTMEDIA RELEASE KIN001 reduced fibrotic damage of the lung in a preclinical fibrosis model Potential as an effe.